publicationMetadata:
  pmid: "PMID:40352015"
  title: "Development of a Machine Learning Algorithm for the Prediction of WHO Grade 1 Meningioma Recurrence."
  queryType: "unknown"
  publicationType: "Clinical Study"
  publicationTypeConfidence: 0.9
  hasMethodsSection: Yes
  likelyContainsTools: Yes
  expectedToolTypes: |
    Clinical Study â†’ clinical assessment tools, computational tools for analysis
    This study develops a machine learning algorithm (computational tool) and uses clinical data analysis.
    May contain statistical software, machine learning frameworks, and potentially clinical assessment tools
    for measuring patient outcomes. No lab research tools expected (antibodies, cell lines, animal models).
  overallAssessment: |
    This is a clinical study developing a machine learning algorithm for predicting meningioma recurrence.
    The study would likely use computational tools (Python, machine learning libraries) and potentially
    clinical assessment tools for measuring patient outcomes. No traditional lab research tools expected.

toolValidations: []

potentiallyMissedTools:
  - toolName: "Risk-calibrated Superspase Linear Integer Model (Risk-SLIM)"
    toolType: "computational_tool"
    foundIn: "abstract"
    contextSnippet: "we used a Risk-calibrated Superspase Linear Integer Model (Risk-SLIM) with a five-fold cross-validation (CV) to create a predictive model"
    whyMissed: "Specific machine learning algorithm/method name not caught by standard software patterns"
    confidence: 0.8
    shouldBeAdded: Yes

  - toolName: "Python version 3.10"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "All statistics and models were conducted in Python version 3.10 (Python Software Foundation, Wilmington, Delaware, US)."
    whyMissed: "Programming language with specific version - standard exclusion but used for custom ML algorithm development"
    confidence: 0.6
    shouldBeAdded: Maybe

  - toolName: "Ki-67/MIB-1 index"
    toolType: "clinical_assessment_tool"
    foundIn: "abstract"
    contextSnippet: "multiple predictive factors of recurrence, including age, female gender, and various histopathologic features, including the Ki-67/MIB-1 index"
    whyMissed: "Clinical biomarker/histopathologic assessment tool not caught by standard patterns"
    confidence: 0.7
    shouldBeAdded: Yes

suggestedPatterns:
  - patternType: "term"
    pattern: "Risk-SLIM|Risk-calibrated.*Linear.*Model"
    toolType: "computational_tool"
    examples: ["Risk-calibrated Superspase Linear Integer Model (Risk-SLIM)"]
    reasoning: "Specific machine learning algorithm that could be used in other NF/tumor prediction studies"

  - patternType: "term"
    pattern: "Ki-67.*index|MIB-1.*index"
    toolType: "clinical_assessment_tool"
    examples: ["Ki-67/MIB-1 index"]
    reasoning: "Important histopathologic biomarker commonly used in tumor studies including NF-related tumors"

  - patternType: "context_phrase"
    pattern: "meningioma recurrence score|MRS.*algorithm"
    toolType: "clinical_assessment_tool"
    examples: ["meningioma recurrence score (MRS) generated by our machine learning algorithm"]
    reasoning: "Clinical scoring system that could be relevant for NF2-related meningioma studies"

observations: []

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 3
  newPatternsCount: 3
  observationsExtracted: 0
  observationsByType: {}
  majorIssuesFound: |
    - No tools were initially mined despite this being a computational study
    - Study develops custom machine learning algorithm (Risk-SLIM) that wasn't detected
    - Clinical biomarker (Ki-67/MIB-1 index) used as assessment tool wasn't caught
    - Python usage for custom algorithm development might warrant inclusion despite general exclusion rule
  recommendations: |
    This publication contains legitimate computational tools that were missed by initial mining.
    The Risk-SLIM algorithm and Ki-67/MIB-1 index should be added as they represent actual research tools.
    Python usage is borderline - while generally excluded, it's used here for custom ML algorithm development.
    No traditional lab research tools expected or found. Focus should be on computational and clinical assessment tools.
    Manual curator should review the Risk-SLIM algorithm as it appears to be a novel/specialized method.